734
Views
10
CrossRef citations to date
0
Altmetric
Review Articles

Recent updates in curcumin delivery

ORCID Icon, & ORCID Icon
Pages 53-64 | Received 20 Feb 2022, Accepted 30 May 2022, Published online: 14 Jun 2022

References

  • Adlia, A., et al., 2018. Antifibrotic activity and in Ovo toxicity study of liver-targeted curcumin-gold nanoparticle. Scientia Pharmaceutica, 86 (4), 41.
  • Ahmadi, F., et al., 2017. Induction of apoptosis in hela cancer cells by an ultrasonic-mediated synthesis of curcumin-loaded chitosan–alginate–sTPP nanoparticles. International Journal of Nanomedicine, 12, 8545–8556.
  • Al Qaraghuli, M.M., et al., 2017a. Where traditional drug discovery meets modern technology in the quest for new drugs. Annals of Pharmacology and Pharmaceutics, 2, 1–5.
  • Al Qaraghuli, M.M., et al., 2017b. Control of malaria by bio-therapeutics and drug delivery systems. Journal of Medical Microbiology & Diagnosis, 6 (3).
  • Alemi, A., et al., 2017. Evaluation of the efficacy of niosomal curcumin nanoformulation in cancer therapy. The Cancer Press, 3(3), 77–85.
  • Aljabali, A. A., Obeid, M. A., 2020. Inorganic-organic nanomaterials for therapeutics and molecular imaging applications. Nanoscience & Nanotechnology-Asia, 10, (6), 748–765
  • Aljabali, A.A., et al., 2019. Gold-coated plant virus as computed tomography imaging contrast agent. Beilstein Journal of Nanotechnology, 10, 1983–1993.
  • Aljabali, A.A., et al., 2021. A potential MRI agent and an anticancer drug encapsulated within CPMV virus-like particles. Combinatorial Chemistry & High Throughput Screening, 24 (10), 1557–1571.
  • Aljabali, A.A., and Obeid, M.A., 2020. Inorganic-organic Nanomaterials for Therapeutics and Molecular Imaging Applications. Nanoscience & Nanotechnology-Asia, 10 (6), 748–765.
  • Alyamani, H., et al., 2019. Exosomes: fighting cancer with cancer. Therapeutic Delivery, 10 (1), 37–61.
  • Amanlou, N., et al., 2019. Enhanced cytotoxic activity of curcumin on cancer cell lines by incorporating into gold/chitosan nanogels. Materials Chemistry and Physics, 226, 151–157.
  • Amawi, H., et al., 2021. The use of zebrafish model in prostate cancer therapeutic development and discovery. Cancer Chemotherapy and Pharmacology, 87 (3), 311-325.
  • Anand, P., et al., 2007. Bioavailability of curcumin: problems and promises. Molecular Pharmaceutics, 4 (6), 807–818.
  • Anwar, M., et al., 2020. Nephroprotective effects of curcumin loaded chitosan nanoparticles in cypermethrin induced renal toxicity in rabbits. Environmental Science and Pollution Research, 27 (13), 14771-14779.
  • Badria, F.A., et al., 2020. Development of provesicular nanodelivery system of curcumin as a safe and effective antiviral agent: statistical optimization, in vitro characterization, and antiviral effectiveness. Molecules, 25 (23), 5668.
  • Bangham, A.D., Standish, M.M., and Watkins, J.C., 1965. Diffusion of univalent ions across the lamellae of swollen phospholipids. Journal of Molecular Biology, 13 (1), 238–IN27.
  • Barenholz, Y.C., 2012. Doxil®—the first FDA-approved nano-drug: lessons learned. Journal of Controlled Release : Official Journal of the Controlled Release Society, 160 (2), 117–134.
  • Belcaro, G., et al., 2010. Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Alternative Medicine Review : A Journal of Clinical Therapeutic, 15 (4), 337–344.
  • BISHT, S., et al., 2010. Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer. Molecular Cancer Therapeutics, 9 (8), 2255–2264.
  • Bisht, S., et al., 2007. Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy. Journal of Nanobiotechnology, 5 (1), 1–18.
  • Bisht, S., et al., 2011. A polymeric nanoparticle formulation of curcumin (NanoCurc™) ameliorates CCl 4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation. Laboratory Investigation, 91 (9), 1383–1395.
  • Bolger, G.T., et al., 2019. Intense uptake of liposomal curcumin by multiple myeloma cell lines: comparison to normal lymphocytes, red blood cells and chronic lymphocytic leukemia cells. Anticancer Research, 39 (3), 1161–1168.
  • Bugno, J., Hsu, H.-J., and Hong, S., 2015. Recent advances in targeted drug delivery approaches using dendritic polymers. Biomaterials Science, 3 (7), 1025–1034.
  • Bulboacă, A.E., et al., 2018. The effect of intravenous administration of liposomal curcumin in addition to sumatriptan treatment in an experimental migraine model in rats. International Journal of Nanomedicine, 13, 3093–3103.
  • Bulboacă, A.E., et al., 2019a. Comparative effect of curcumin versus liposomal curcumin on systemic pro-inflammatory cytokines profile, MCP-1 and RANTES in experimental diabetes mellitus. International Journal of Nanomedicine, 14, 8961–8972.
  • Bulboacă, A.E., et al., 2019b. Liposomal curcumin enhances the effect of naproxen in a rat model of migraine. Medical Science Monitor, 25, 5087–5097.
  • Bulboacă, A.E., et al., 2019c. Liposomal curcumin is better than curcumin to alleviate complications in experimental diabetic mellitus. Molecules, 24 (5), 846.
  • Bulboacă, A.E., et al., 2021. Protective Effects of Liposomal Curcumin on Oxidative Stress/Antioxidant Imbalance, Metalloproteinases 2 and-9, Histological Changes and Renal Function in ExperimentalNephrotoxicity Induced by Gentamicin. Antioxidants, 10 (2), 325.
  • Calzoni, E., et al., 2019. Biocompatible polymer nanoparticles for drug delivery applications in cancer and neurodegenerative disorder therapies. Journal of Functional Biomaterials, 10 (1), 4.
  • Chandran, B., and Goel, A., 2012. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytotherapy Research: PTR, 26 (11), 1719–1725.
  • Chen, Y.-N., et al., 2016. Ameliorative effect of curcumin-encapsulated hyaluronic acid–PLA nanoparticles on thioacetamide-induced murine hepatic fibrosis. International Journal of Environmental Research and Public Health, 14 (1), 11.
  • Chun, Y.S., et al., 2012. Intraductal administration of a polymeric nanoparticle formulation of curcumin (NanoCurc) significantly attenuates incidence of mammary tumors in a rodent chemical carcinogenesis model: implications for breast cancer chemoprevention in at-risk populations. Carcinogenesis, 33 (11), 2242–2249.
  • Colone, M., Calcabrini, A., and Stringaro, A., 2020. Drug delivery systems of natural products in oncology. Molecules, 25 (19), 4560.
  • Costa, P.M., et al., 2016. Functionalized carbon nanotubes: from intracellular uptake and cell-related toxicity to systemic brain delivery. Journal of Controlled Release : official Journal of the Controlled Release Society, 241, 200–219.
  • Cuomo, J., et al., 2011. Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. Journal of Natural Products, 74 (4), 664–669.
  • Dang, Y., and Guan, J., 2020. Nanoparticle-based drug delivery systems for cancer therapy. Smart Materials in Medicine, 1, 10–19.
  • Das, K., et al., 2017. An integrin-targeting RGDK-tagged nanocarrier: anticancer efficacy of loaded curcumin. ChemMedChem., 12 (10), 738–750.
  • Das, M., et al., 2020. Carbon nanotube embedded cyclodextrin polymer derived injectable nanocarrier: A multiple faceted platform for stimulation of multi-drug resistance reversal. Carbohydrate Polymers, 247, 116751.
  • Dcodhar, S., Sethi, R., and Srimal, R., 2013. Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). Indian Journal of Medical Research, 138,
  • Dogaru, G., et al., 2020. Effect of liposomal curcumin on acetaminophen hepatotoxicity by down-regulation of oxidative stress and matrix metalloproteinases. In Vivo (Athens, Greece), 34 (2), 569–582.
  • Dolati, S., et al., 2019. Nanocurcumin improves regulatory T-cell frequency and function in patients with multiple sclerosis. Journal of Neuroimmunology, 327, 15–21.
  • Elhissi, A., et al., 2012. Carbon nanotubes in cancer therapy and drug delivery. Journal of Drug Delivery, 2012, 1–10.
  • Feng, T., et al., 2017. Liposomal curcumin and its application in cancer. International Journal of Nanomedicine, 12, 6027–6044.
  • Gamage, N., et al., 2016. Targeted theranostic approach for glioma using dendrimer-based curcumin nanoparticle. Journal of Nanomedicine & Nanotechnology, 7,
  • Gebril, A., et al., 2022. Mucosal and systemic immune responses following mucosal immunisation of tetanus toxoid entrapped in lipid nanoparticles prepared by microwave reactor. European Journal of Pharmaceutics and Biopharmaceutics, 171, 11–18.
  • Germain, M., et al., 2020. Delivering the power of nanomedicine to patients today. Journal of Controlled Release : official Journal of the Controlled Release Society, 326, 164–171.
  • Ghaffari, M., et al., 2020. Co-delivery of curcumin and Bcl-2 siRNA by PAMAM dendrimers for enhancement of the therapeutic efficacy in HeLa cancer cells. Colloids and Surfaces. B, Biointerfaces, 188, 110762.
  • Ghosh, S., et al., 2009. Increased heating efficiency and selective thermal ablation of malignant tissue with DNA-encased multiwalled carbon nanotubes. ACS Nano, 3 (9), 2667–2673.
  • Giordano, A., and Tommonaro, G., 2019. Curcumin and cancer. Nutrients, 11, 2376.
  • Han, J., et al., 2018. Polymer-based nanomaterials and applications for vaccines and drugs. Polymers, 10 (1), 31.
  • Handjani-Vila, R., et al., 1979. Dispersions of lamellar phases of non-ionic lipids in cosmetic products. International Journal of Cosmetic Science, 1 (5), 303–314.
  • Hardiansyah, A., et al., 2017. Hydrophobic drug-loaded PEGylated magnetic liposomes for drug-controlled release. Nanoscale Research Letters, 12 (1), 1–11.
  • Hasan, M., et al., 2020. Growth-inhibitory effect of chitosan-coated liposomes encapsulating curcumin on MCF-7 breast cancer cells. Marine Drugs, 18 (4), 217.
  • Hashemian, M., et al., 2017. Curcumin-loaded chitosan-alginate-STPP nanoparticles ameliorate memory deficits and reduce glial activation in pentylenetetrazol-induced kindling model of epilepsy. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 79 (Pt B), 462–471.
  • Hillery, A. M., Lloyd, A. W., and Swarbrick, J., 2002. Drug delivery and targeting: for pharmacists and pharmaceutical scientists, CRC Press.
  • Hindumathi, R., et al., 2018. Novel nano-cocoon like structures of polyethylene glycol–multiwalled carbon nanotubes for biomedical applications. Nano-Structures & Nano-Objects, 13, 30–35.
  • Hu, X., et al., 2020. Multifunctional gold nanoparticles: a novel nanomaterial for various medical applications and biological activities. Frontiers in Bioengineering and Biotechnology, 8, 990.
  • INSTITUTE, N. C. 2021. Curcumin/Doxorubicin-encapsulating nanoparticle imx-110 (code C154569) [Online]. Available: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C154569 [Accessed 2021].
  • Jahromi, H.K., et al., 2020. Enhanced sciatic nerve regeneration by poly-L-lactic acid/multi-wall carbon nanotube neural guidance conduit containing Schwann cells and curcumin encapsulated chitosan nanoparticles in rat. Materials Science & Engineering. C, Materials for Biological Applications, 109, 110564.
  • Joshi, R.P., et al., 2013. SNEDDS curcumin formulation leads to enhanced protection from pain and functional deficits associated with diabetic neuropathy: an insight into its mechanism for neuroprotection. Nanomedicine: Nanotechnology, Biology and Medicine, 9 (6), 776–785.
  • Khan, M.M., et al., 2020. Co-delivery of curcumin and cisplatin to enhance cytotoxicity of cisplatin using lipid-chitosan hybrid nanoparticles. International Journal of Nanomedicine, 15, 2207–2217.
  • Kharat, M., et al., 2017. Physical and chemical stability of curcumin in aqueous solutions and emulsions: impact of pH, temperature, and molecular environment. Journal of Agricultural and Food Chemistry, 65 (8), 1525–1532.
  • Kong, F.-Y., et al., 2017. Unique roles of gold nanoparticles in drug delivery, targeting and imaging applications. Molecules, 22 (9), 1445.
  • Lev-Ari, S., et al., 2006. Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity. Anticancer Research, 26 (6B), 4423–4430.
  • Li, H., et al., 2014a. Formulation of curcumin delivery with functionalized single-walled carbon nanotubes: characteristics and anticancer effects in vitro. Drug Delivery, 21 (5), 379–387.
  • Li, H., et al., 2019. Enhancement of curcumin antitumor efficacy and further photothermal ablation of tumor growth by single-walled carbon nanotubes delivery system in vivo. Drug Delivery, 26 (1), 1017–1026.
  • Li, S., et al., 2014b. Curcumin lowers erlotinib resistance in non-small cell lung carcinoma cells with mutated EGF receptor. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, 21 (3), 137–144.
  • Literat, A., et al., 2001. Regulation of pro-inflammatory cytokine expression by curcumin in hyaline membrane disease (HMD). Life Sciences, 70 (3), 253–267.
  • Liu, Y., et al., 2019. In vivo evaluation of enhanced drug carrier efficiency and cardiac anti-hypertrophy therapeutic potential of nano-curcumin encapsulated photo-plasmonic nanoparticles combined polymerized nano-vesicles: A novel strategy. Journal of Photochemistry and Photobiology B: Biology, 199, 111619.
  • Mahalunkar, S., et al., 2019. Functional design of pH-responsive folate-targeted polymer-coated gold nanoparticles for drug delivery and in vivo therapy in breast cancer. International Journal of Nanomedicine, 14, 8285–8302.
  • Manju, S., and Sreenivasan, K., 2012. Gold nanoparticles generated and stabilized by water soluble curcumin–polymer conjugate: blood compatibility evaluation and targeted drug delivery onto cancer cells. Journal of Colloid and Interface Science, 368 (1), 144–151.
  • Mantovani, A., 2010. Molecular pathways linking inflammation and cancer. Current Molecular Medicine, 10 (4), 369–373.
  • Marslin, G., et al., 2018. Oral delivery of curcumin polymeric nanoparticles ameliorates CCl4-induced subacute hepatotoxicity in wistar rats. Polymers, 10 (5), 541.
  • Mukherjee, A., et al., 2019. Lipid–polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives. International Journal of Nanomedicine, 14, 1937–1952.
  • Mungroo, M.R., et al., 2020. Gold-conjugated curcumin as a novel therapeutic agent against brain-eating amoebae. ACS Omega, 5 (21), 12467–12475.
  • Naeimi, R., et al., 2018. Curcumin-loaded nanoparticles ameliorate glial activation and improve myelin repair in lyolecithin-induced focal demyelination model of rat corpus callosum. Neuroscience Letters, 674, 1–10.
  • Nagahama, K., et al., 2016. Discovery of a new function of curcumin which enhances its anticancer therapeutic potency. Scientific Reports, 6 (1), 1–14.
  • Nanjwade, B.K., et al., 2009. Dendrimers: emerging polymers for drug-delivery systems. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences, 38 (3), 185–196.
  • Nasri, H., et al., 2014. Turmeric: A spice with multifunctional medicinal properties. Journal of HerbMed Pharmacology, 3.
  • Obeid, M. A., et al., 2018. Lipid-based nanoparticles for cancer treatment. In Lipid nanocarriers for drug targeting, pp. 313-359. William Andrew Publishing.
  • Obeid, M. A., et al., 2020a. Carbon nanotubes in nucleic acids delivery.
  • Obeid, M. A., et al., 2021b. Sirna delivery to melanoma cells with cationic niosomes. In Melanoma (pp. 621-634). New York, NY: Humana.
  • Obeid, M.A., et al., 2019a. Proof of concept studies for siRNA delivery by nonionic surfactant vesicles: in vitro and in vivo evaluation of protein knockdown. Journal of Liposome Research, 29 (3), 229–238.
  • Obeid, M.A., et al., 2019b. Microfluidic manufacturing of different niosomes nanoparticles for curcumin encapsulation: Physical characteristics, encapsulation efficacy, and drug release. Beilstein Journal of Nanotechnology, 10, 1826–1832.
  • Obeid, M.A., et al., 2020b. Niosome-encapsulated balanocarpol: compound isolation, characterisation, and cytotoxicity evaluation against human breast and ovarian cancer cell lines. Nanotechnology, 31 (19), 195101.
  • Obeid, M.A., et al., 2021a. Examination of the effect of niosome preparation methods in encapsulating model antigens on the vesicle characteristics and their ability to induce immune responses. Journal of Liposome Research, 31 (2), 195-202.
  • Obeid, M.A., et al., 2021b. Use of nanoparticles in delivery of nucleic acids for melanoma treatment. Methods in Molecular Biology (Clifton, NJ), 2265, 591–620.
  • Orunoğlu, M., et al., 2017. Effects of curcumin-loaded PLGA nanoparticles on the RG2 rat glioma model. Materials Science and Engineering: C, 78, 32–38.
  • Palange, A.L., et al., 2014. Lipid–polymer nanoparticles encapsulating curcumin for modulating the vascular deposition of breast cancer cells. Nanomedicine: Nanotechnology, Biology and Medicine, 10 (5), e991–e1002.
  • Prasad, S., and Aggarwal, B. B., 2011. Turmeric, The golden spice. Herbal medicine: Biomolecular and clinical aspects. 2nd ed.
  • Rahimi-Moghaddam, F., Sattarahmady, N., and Azarpira, N., 2019. Gold-curcumin nanostructure in photo-thermal therapy on breast cancer cell line: 650 and 808 nm diode lasers as light sources. Journal of Biomedical Physics & Engineering, 9, 473.
  • Ray, B., et al., 2011. Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc™) in the neuronal cell culture and animal model: implications for Alzheimer's disease. Journal of Alzheimer's Disease : JAD, 23 (1), 61–77.
  • Reilly, R.M., 2007. Carbon nanotubes: potential benefits and risks of nanotechnology in nuclear medicine. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 48 (7), 1039–1042.
  • Saber‐Moghaddam, N., et al., 2021. Oral nano‐curcumin formulation efficacy in Management of mild to moderate hospitalized coronavirus disease‐19 patients: An open label nonrandomized clinical trial. Phytotherapy Research, 35 (5), 2616–2623.
  • Sahab-Negah, S., et al., 2020. Curcumin loaded in niosomal nanoparticles improved the anti-tumor effects of free curcumin on glioblastoma stem-like cells: an in vitro study. Molecular Neurobiology, 57 (8), 3391–3411.
  • Salehi, B., et al., 2019. The therapeutic potential of curcumin: A review of clinical trials. European Journal of Medicinal Chemistry, 163, 527–545.
  • Sandoval-Yañez, C., and Castro Rodriguez, C., 2020. Dendrimers: Amazing platforms for bioactive molecule delivery systems. Materials, 13 (3), 570.
  • Sangboonruang, S., et al., 2021. Potentiality of melittin-loaded niosomal vesicles against vancomycin-intermediate Staphylococcus aureus and Staphylococcal skin infection. International Journal of Nanomedicine, 16, 7639–7661.
  • Sasaki, H., et al., 2011. Innovative preparation of curcumin for improved oral bioavailability. Biological & Pharmaceutical Bulletin, 34 (5), 660–665.
  • Sato, K., and Anzai, J.-I., 2013. Dendrimers in layer-by-layer assemblies: Synthesis and applications. Molecules, 18 (7), 8440–8460.
  • Schmitt, C., et al., 2020. Liposomal encapsulated curcumin effectively attenuates neuroinflammatory and reactive astrogliosis reactions in glia cells and organotypic brain slices. International Journal of Nanomedicine, 15, 3649–3667.
  • Shukla, M., et al., 2017. A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin. Drug Development and Industrial Pharmacy, 43 (5), 847–861.
  • Siddique, S., and Chow, J.C., 2020. Gold nanoparticles for drug delivery and cancer therapy. Applied Sciences, 10 (11), 3824.
  • Singh, N., Sachdev, A., and Gopinath, P., 2018a. Polysaccharide functionalized single walled carbon nanotubes as nanocarriers for delivery of curcumin in lung cancer cells. Journal of Nanoscience and Nanotechnology, 18 (3), 1534–1541.
  • Singh, P., et al., 2018b. Gold nanoparticles in diagnostics and therapeutics for human cancer. International Journal of Molecular Sciences, 19 (7), 1979.
  • Storka, A., et al., 2015. Safety, tolerability and pharmacokinetics of liposomal curcumin (Lipocurc™) in healthy humans. Int. Journal of Clinical Pharmacology and Therapeutics, 53 (01), 54–65.
  • Thomas, O.S., and Weber, W., 2019. Overcoming physiological barriers to nanoparticle delivery—are we there yet? Frontiers in Bioengineering and Biotechnology, 7, 415.
  • Tomeh, M.A., Hadianamrei, R., and Zhao, X., 2019. A review of curcumin and its derivatives as anticancer agents. International Journal of Molecular Sciences, 20 (5), 1033.
  • Uchegbu, I.F., and Florence, A.T., 1995. Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry. Advances in Colloid and Interface Science, 58 (1), 1–55.
  • Uchegbu, I.F., and Vyas, S.P., 1998. Non-ionic surfactant based vesicles (niosomes) in drug delivery. International Journal of Pharmaceutics, 172 (1-2), 33–70.
  • Velayudhan, K., Dikshit, N., and Nizar, M. A., 2012. Ethnobotany of turmeric (Curcuma longa L.).
  • Wang, W.-Y., et al., 2019. Delivery of folic acid-modified liposomal curcumin for targeted cervical carcinoma therapy. Drug Design, Development and Therapy, Volume 13, 2205–2213.
  • Watkins, R., et al., 2015. Natural product-based nanomedicine: recent advances and issues. International Journal of Nanomedicine, 10, 6055–6074.
  • Xu, H., et al., 2018. Liposomal curcumin targeting endometrial Cancer through the NF-κB pathway. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 48 (2), 569–582.
  • Xu, S., et al., 2019. Precise ratiometric co-loading, co-delivery and intracellular co-release of paclitaxel and curcumin by aid of their conjugation to the same gold nanorods to exert synergistic effects on MCF-7/ADR cells. Journal of Drug Delivery Science and Technology, 54, 101383.
  • Xu, Y.-Q., et al., 2016. Niosome encapsulation of curcumin: characterization and cytotoxic effect on ovarian cancer cells. Journal of Nanomaterials.
  • Yuan, S., et al., 2016. Functionalized single-walled carbon nanotubes for the improved solubilization and delivery of curcumin. Fullerenes, Nanotubes and Carbon Nanostructures, 24 (1), 13–19.
  • Zhang, L., and Zhang, L., 2010. Lipid–polymer hybrid nanoparticles: synthesis, characterization and applications. Nano Life, 01 (01n02), 163–173.
  • Zhang, L., et al., 2008. Self-assembled lipid-polymer hybrid nanoparticles: a robust drug delivery platform. ACS Nano, 2 (8), 1696–1702.
  • Zhou, F., et al., 2009. Cancer photothermal therapy in the near-infrared region by using single-walled carbon nanotubes. Journal of Biomedical Optics, 14 (2), 021009.
  • Zhu, Y., Liu, C., and Pang, Z., 2019. Dendrimer-based drug delivery systems for brain targeting. Biomolecules, 9 (12), 790.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.